Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study
Sign Up to like & getrecommendations! Published in 2025 at "Archives of Dermatological Research"
DOI: 10.1007/s00403-025-04090-5
Abstract: Atopic dermatitis is a chronic inflammatory systemic disease that can persist or start in adulthood, even in elderly age, with several clinical phenotypes. The aim of this study was to evaluate the relationship between phenotype… read more here.
Keywords: week; effects dupilumab; phenotype endotype; dupilumab therapy ... See more keywords
Long‐term real‐world experience of the side effects of dupilumab in 128 patients with atopic dermatitis and related conditions aged 6 years and above: Retrospective chart analysis from a single tertiary care center
Sign Up to like & getrecommendations! Published in 2022 at "Dermatologic Therapy"
DOI: 10.1111/dth.15415
Abstract: Dupilumab is a monoclonal antibody against interleukins 4 and 13 currently FDA approved for the treatment of moderate to severe atopic dermatitis (AD) in adults and adolescents and severe AD in children aged 6–11 years. It… read more here.
Keywords: effects dupilumab; side; side effects; aged years ... See more keywords